New Cannabis-Based Pain Medication Enters U.S. Trials: What Arkansas Patients Should Know
Updated: 4 hours ago
Don’t miss important updates about Arkansas’s marijuana program. Subscribe to our newsletter and get the latest straight to your email!
Could cannabis-based medicine offer another approach to treating chronic pain? A new clinical trial in the United States is investigating that possibility, adding to growing research into the potential medical applications of marijuana.
For Arkansas residents living with chronic pain, the study offers an interesting look at how scientists are working to better understand cannabinoids and their effects on the body.
Researchers in New York are evaluating VER-01, an experimental cannabis-derived medication developed specifically for chronic lower back pain. The medication has already shown promising results in European clinical trials, and researchers are now studying its safety and effectiveness in American patients.
Although VER-01 is not currently available through Arkansas medical marijuana dispensaries, the research could contribute to a better understanding of cannabis-based pain treatments.
A New Approach to Studying Marijuana for Chronic Pain
Chronic pain can affect nearly every aspect of daily life, from maintaining a regular sleep schedule to working, exercising, and completing everyday activities.
For some patients, conventional treatments provide sufficient relief. Others continue to experience pain despite trying medications, physical therapy, or other approaches.
This has encouraged researchers to investigate alternative pain management strategies, including medications developed from cannabis compounds.
VER-01 is one example of this research.
Developed by German pharmaceutical company Vertanical, VER-01 is a standardized marijuana extract containing multiple cannabinoids. Unlike traditional marijuana products, its formulation is carefully controlled so researchers can evaluate consistent doses in clinical studies.
The medication contains:
THC (tetrahydrocannabinol): THC is the primary intoxicating cannabinoid in marijuana, which interacts with receptors involved in pain signaling and other bodily functions.
CBD (cannabidiol): CBD is a non-intoxicating cannabinoid being investigated for its potential therapeutic applications.
CBG (cannabigerol): CBG is a lesser-known cannabinoid that researchers are studying for its possible effects on inflammation and other biological processes.
Together, these compounds are being investigated as part of a specific pharmaceutical formulation rather than as a conventional dispensary product.
What Researchers Hope to Learn From the U.S. Trial
According to NORML's October 2026 report, researchers at Upstate Clinical Research Associates in Williamsville, New York, are participating in a clinical trial examining VER-01 for chronic lower back pain.
The study focuses on individuals whose pain has not responded adequately to opioid-based treatments.
Using a placebo-controlled design, investigators are evaluating whether the medication can produce measurable improvements compared with an inactive treatment.
Researchers are interested in several outcomes, including pain intensity, sleep quality, physical functioning, and potential side effects.
These findings could help determine whether VER-01 warrants further development as a prescription medication for chronic pain.
European Research Has Already Produced Encouraging Results
The American study follows previous research conducted in Europe.
A Phase 3 study published in Nature Medicine examined VER-01 in 820 adults experiencing chronic lower back pain.
Researchers reported that participants receiving VER-01 experienced an average pain reduction of 1.9 points on an 11-point scale, compared with 1.4 points among participants receiving a placebo.
The study also identified improvements in measures related to sleep, physical functioning, and quality of life.
Additional research published in Pain and Therapy compared VER-01 with opioid medications in 384 adults.
Over six months, researchers observed slightly greater average improvements in pain and sleep among participants receiving VER-01, along with lower rates of constipation.
While these results are promising, the studies do not establish that marijuana products generally are more effective or safer than opioids. The findings relate to a particular investigational medication, and additional research is necessary.
What This Research Means for Arkansas Medical Marijuana Patients
Arkansas has an established medical marijuana program that allows eligible patients with qualifying medical conditions to access cannabis products through licensed dispensaries.
One of the state's qualifying conditions is intractable pain, which Arkansas defines as pain that has not responded to ordinary medications, treatment, or surgical measures for more than six months.
This makes ongoing marijuana research particularly relevant to Arkansas patients who are exploring available options for managing persistent pain.
However, it is important to distinguish VER-01 from the products currently sold at Arkansas medical marijuana dispensaries.
The investigational medication uses a standardized cannabinoid formulation, while dispensary products can vary in potency, cannabinoid concentrations, delivery methods, and other characteristics.
As a result, findings from VER-01 clinical trials cannot automatically be applied to marijuana flower, tinctures, edibles, or other products found at Arkansas dispensaries.
Patients should discuss their symptoms, medical history, medications, and treatment goals with a qualified medical marijuana doctor before making decisions about their healthcare.
Is VER-01 Available in Arkansas?
No. VER-01 remains an investigational medication and has not received FDA approval for general medical use.
The FDA has granted the medication Breakthrough Therapy Designation, which may help accelerate its development and review.
However, this designation does not guarantee that the medication will ultimately receive approval.
VER-01 is not currently an approved prescription treatment or a product available through Arkansas medical marijuana dispensaries.
For now, Arkansas patients must follow the state's existing medical marijuana laws and registration requirements when seeking access to regulated marijuana products.
How to Qualify for Medical Marijuana in Arkansas
Arkansas residents may qualify for a medical marijuana card if they have a medical condition recognized under state law and receive written certification from a licensed Arkansas physician.
Qualifying conditions include:
A chronic or debilitating disease/medical condition/treatment that produces one or more of the following:
Intractable pain, or pain that has not responded to ordinary treatment or surgical methods for more than 6 months
Severe and persistent muscle spasms, including those characteristics of multiple sclerosis (MS)
Any other medical condition or its treatment approved by the Arkansas Board of Health
Once certified, patients must complete the registration process through the Arkansas Department of Health (ADH) and receive an approved medical marijuana identification card before purchasing marijuana from a licensed Arkansas dispensary.
Renewing Your Arkansas Medical Marijuana Card
If you already have an Arkansas medical marijuana card, you can renew it through a telemedicine appointment with Arkansas Marijuana Card. Arkansas allows eligible patients to complete their recertification evaluations through telehealth, making it easier to maintain access without traveling to an office.
Our renewal process includes:
A convenient telemedicine evaluation with a qualified healthcare professional.
A new physician certification for your renewal application.
Guidance on completing and submitting your renewal application to the Arkansas Department of Health.
Assistance with questions about your application and card status.
You can begin the renewal process up to 60 days before your current card expires. The state may take up to 14 days to process a completed renewal application.
Note: Arkansas allows telehealth for recertification, but initial medical marijuana certifications cannot be issued through a telemedicine evaluation.
The Future of Marijuana Research and Pain Management
The VER-01 clinical trial represents another effort to better understand how specific cannabis-derived compounds may be used in medicine.
For Arkansas patients, this research underscores the importance of continued scientific investigation, responsible medical oversight, and access to reliable information about marijuana-based treatments.
While VER-01 may eventually become another option for certain patients, researchers must first establish that its benefits outweigh its risks.
Until then, patients considering medical marijuana should focus on understanding Arkansas's existing program and discussing their individual circumstances with a qualified physician.
Renew Your Medical Marijuana Card Today!
Medical marijuana is legal in Arkansas, and we can help you renew your medical card TODAY! If you qualify for your renewal, give us a call, and we can help!
You need your medical card to access any of Arkansas’s medical dispensaries. Not to worry, because it is now easier than ever to renew your card with Arkansas Marijuana Card!
Telemedicine makes it easy for you to renew your card from the comfort of your own home! Schedule an appointment with one of our doctors to get started today!
Doctors Who Care
Relief You Can Trust
Here at Arkansas Marijuana Card, we aim to help everyone achieve wellness safely and conveniently through increased access to medical marijuana. Our focus on education, inclusion, and acceptance will reduce the stigma for our patients by providing equal access to timely information and compassionate care.
Call us at (844)-249-8714 today, or book an appointment here.
For more blogs like this, plus patient resources and state updates, sign up for our newsletter!
Comments